Memory improving composition comprising arillus longan, semen nelumbinis, poria and semen juglandis

US10376552B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10376552-B2
Application numberUS-201615252528-A
CountryUS
Kind codeB2
Filing dateAug 31, 2016
Priority dateSep 10, 2015
Publication dateAug 13, 2019
Grant dateAug 13, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to the technical field of health food, and discloses a memory improving composition and the preparation method and use thereof. The composition is made from Arillus Longan, Poria, Semen Nelumbinis, enzymatic extract of Semen Juglandis, phosphatidylserine and taurine. In the present invention, the sovereign drug Arillus Longan is combined with ministerial drugs Poria and Semen Nelumbinis to synergistically achieve the effect of nourishing heart for tranquillization and tonifying kidney & invigorating spleen. They are further combined with enzymatic extract of Semen Juglandis improving brain metabolism and enhances memory, functional factor phosphatidylserine increasing fluidity and enhances plasticity of cell membrane, and taurine improving memory, to achieve the purpose of memory improvement together. All kinds of raw materials are medicine homologous and new resource food, which are safe, have no toxic and side effects, and thus can be consumed as health food over a long period of time.

First claim

Opening claim text (preview).

The invention claimed is: 1. A memory improving composition, which is made from materials consisting of 200-800 parts of Arillus Longan, 200-800 parts of Semen Nelumbinis, 200-800 parts of Poria, 10-150 parts of enzymatic extract of Semen Juglandis, 10-150 parts of phosphatidylserine, and 3-50 parts of taurine, wherein the enzymatic extract of Semen Juglandis is a hydrolysate of Semen Juglandis dregs after hydrolyzation with alkaline endoprotease Alcalase™ ( Bacillus protease preparation) 2.4L and complex protease Protamex™ ( Bacillus protease preparation); wherein the enzymatic extract of Semen Juglandis is prepared by the following method: (a) grinding Semen Juglandis dregs in water to obtain a slurry of Semen Juglandis dregs, adding alkali to adjust the pH value to 8.0 to 9.0, centrifuging, removing impurities in the supernatant enzymatically, adding acid to cause precipitation, washing the precipitate to obtain a walnut protein; (b) hydrolyzing the walnut protein to a hydrolysis degree of 8-12% with alkaline endoprotease Alcalase™ 2.4L and complex protease Protamex™, and collecting the supernatant as enzymatic hydrolysate of walnut protein after enzyme deactivation and centrifugation; (c) enriching enzymatic extract of Semen Juglandis by separating the enzymatic hydrolysate of walnut protein through a filter cloth and ultrafiltration membrane. 2. The composition according to claim 1 , which is prepared by extracting Arillus Longan, Poria and Semen Nelumbinis by water decoction, and mixing with enzymatic extract of Semen Juglandis, phosphatidylserine and taurine. 3. The composition according to claim 1 , wherein removing impurities in the supernatant enzymatically in the step (a) is carried out by adding 1% of α-amylase and 0.5% of cellulase relative to the total weight of the Semen Juglandis dregs to the supernatant. 4. The composition according to claim 1 , wherein the step (b) is carried out as follows: stirring the walnut protein with addition of water, adding alkaline endoprotease Alcalase™ 2.4L in an amount of 2000-3000 U/g protein and complex protease Protamex™ in an amount of 1200-2500 U/g protein, hydrolyzing to a hydrolysis degree of 8-12% at 50-55° C., and collecting the supernatant after enzyme deactivation and centrifugation to obtain the enzymatic hydrolysate of walnut protein. 5. The composition according to claim 1 , wherein the step (c) is carried out as follows: filtering the enzymatic hydrolysate of walnut protein through a 100 mesh filter cloth, then through an ultrafiltration membrane with a membrane flux of 10000 Da, producing a permeation liquid, then filtering the permeation liquid through an ultrafiltration membrane with a membrane flux of 1000 Da, collecting a retentate to obtain a walnut polypeptide solution, concentrating under vacuum to achieve a solid content of 30-40% and spray drying to obtain the enzymatic extract of Semen Juglandis.

Assignees

Inventors

Classifications

  • for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia · CPC title

  • using water, e.g. cold water, infusion, tea, steam distillation or decoction · CPC title

  • Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

  • from plants · CPC title

  • Poria · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10376552B2 cover?
The present invention relates to the technical field of health food, and discloses a memory improving composition and the preparation method and use thereof. The composition is made from Arillus Longan, Poria, Semen Nelumbinis, enzymatic extract of Semen Juglandis, phosphatidylserine and taurine. In the present invention, the sovereign drug Arillus Longan is combined with ministerial drugs Pori…
Who is the assignee on this patent?
Infinitus China Co Ltd
What technology area does this patent fall under?
Primary CPC classification A61K36/52. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).